# Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

> **NCT02312401** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 120 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** multi-parametric MRI(MP-MRI)
- **DEVICE:** dynamic contrast-enhanced MRI (DCE)
- **PROCEDURE:** biopsy

## Key facts

- **NCT ID:** NCT02312401
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312401, "Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02312401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*